Follow
Daniel Alcolea
Daniel Alcolea
Sant Pau Memory Unit - Hospital de la Santa Creu i Sant Pau - Barcelona (Spain)
Verified email at santpau.cat - Homepage
Title
Cited by
Cited by
Year
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
14722015
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...
Nature genetics 54 (4), 412-436, 2022
8132022
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
G Kleinberger, Y Yamanishi, M Suárez-Calvet, E Czirr, E Lohmann, ...
Science translational medicine 6 (243), 243ra86-243ra86, 2014
7222014
sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ...
EMBO molecular medicine 8 (5), 466-476, 2016
4422016
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
3962013
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World …
P Lewczuk, P Riederer, SE O’bryant, MM Verbeek, B Dubois, PJ Visser, ...
The world journal of biological psychiatry 19 (4), 244-328, 2018
2452018
Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study
FH Duits, P Martinez‐Lage, C Paquet, S Engelborghs, A Lleo, L Hausner, ...
Alzheimer's & Dementia 12 (2), 154-163, 2016
2312016
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
J Fortea, E Vilaplana, M Carmona-Iragui, B Benejam, L Videla, I Barroeta, ...
The Lancet 395 (10242), 1988-1997, 2020
2122020
Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease
P Podlesniy, J Figueiro‐Silva, A Llado, A Antonell, R Sanchez‐Valle, ...
Annals of neurology 74 (5), 655-668, 2013
2082013
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
R Chia, MS Sabir, S Bandres-Ciga, S Saez-Atienzar, RH Reynolds, ...
Nature genetics 53 (3), 294-303, 2021
2072021
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk
Y Deming, F Filipello, F Cignarella, C Cantoni, S Hsu, R Mikesell, Z Li, ...
Science translational medicine 11 (505), eaau2291, 2019
2052019
Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes
N Setó-Salvia, J Clarimón, J Pagonabarraga, B Pascual-Sedano, ...
Archives of neurology 68 (3), 359-364, 2011
1712011
Reduced slow-wave sleep is associated with high cerebrospinal fluid Aβ42 levels in cognitively normal elderly
AW Varga, ME Wohlleber, S Giménez, S Romero, JF Alonso, EL Ducca, ...
Sleep 39 (11), 2041-2048, 2016
1702016
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ...
Nature communications 12 (1), 3417, 2021
1682021
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
D Alcolea, P Martínez-Lage, P Sánchez-Juan, J Olazarán, C Antúnez, ...
Neurology 85 (7), 626-633, 2015
1682015
Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia
WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ...
JAMA psychiatry 75 (1), 84-95, 2018
1642018
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
J Fortea, M Carmona-Iragui, B Benejam, S Fernández, L Videla, ...
The Lancet Neurology 17 (10), 860-869, 2018
1622018
Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer's disease cerebrospinal fluid
A Lleó, R Núñez-Llaves, D Alcolea, C Chiva, D Balateu-Paños, ...
Molecular & Cellular Proteomics 18 (3), 546-560, 2019
1492019
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia
O Dols-Icardo, A García-Redondo, R Rojas-García, R Sánchez-Valle, ...
Human molecular genetics 23 (3), 749-754, 2014
1432014
Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer disease
J Fortea, E Vilaplana, D Alcolea, M Carmona‐Iragui, ...
Annals of neurology 76 (2), 223-230, 2014
1352014
The system can't perform the operation now. Try again later.
Articles 1–20